Morning bright light therapy improved mood and MRI markers linked to the brain's waste-clearance system in young adults with early depressive symptoms.
Early depressive symptoms often precedes major depressive disorder, but preventive strategies that target underlying brain biology are scarce. In a randomized trial, researchers examined whether daily morning bright light could reduce symptoms while altering brain imaging markers related to the glymphatic system, which moves cerebrospinal fluid through channels surrounding blood vessels in the brain to help clear metabolic waste.
Enjoying this research? Get deeper insights like this delivered every other week.
Every other week our Premium Members receive deep dives like this alongside Rhonda's commentary and 8+ other hand-picked papers.
The study followed 110 adults ages 18 to 28 who had persistent depressive symptoms but did not meet the full criteria for major depression. Participants used either a 5,000-lux light box (brightness of outdoor light on an overcast day) or a placebo device that emitted very dim light (less than 5 lux) for 30 minutes each morning for 8 weeks. Researchers measured depressive symptoms and anhedonia (reduced ability to feel pleasure) before and after the 8-week intervention. They also examined several brain and immune markers.
- After 8 weeks, those using bright light showed greater reductions in depressive symptoms and larger improvements in anhedonia scores.
- Bright light increased an indirect MRI-based measure of glymphatic-related fluid movement along small blood vessels in the brain. Other fluid-related measures associated with the glymphatic system did not show clear differences between groups.
- Resting-state brain scans showed more synchronized local activity in the left superior frontal gyrus after bright light therapy, while this pattern declined in the placebo group. The increase suggests a shift toward normalization in a region involved in emotion and reward regulation.
- In a subgroup who provided blood samples, levels of the inflammatory signaling proteins interleukin-9 (IL-9) and tumor necrosis factor-beta (TNF-β) decreased after bright light treatment. However, these reductions were not clearly greater than placebo when directly compared.
- Exploratory analyses within the bright light group showed that larger increases in the MRI measure linked to fluid movement were associated with greater improvements in anhedonia, more synchronized brain activity, and lower inflammatory markers.
The activity of the glymphatic system rises during sleep and is regulated by circadian rhythm, the internal 24-hour clock that governs sleep–wake timing. Morning light is the strongest signal for aligning this clock. When circadian timing is stable, sleep tends to be more regular and restorative, which supports fluid movement along brain vessels. Efficient waste clearance and stable sleep are also important for maintaining balanced activity in the prefrontal cortex and keeping inflammatory signaling in check. By reinforcing circadian timing, bright morning light exposure may therefore help reduce depressive symptoms.
The study relied on indirect imaging markers, a limited immune panel, and a narrow young adult sample without long-term follow-up. If future studies in broader populations confirm these results, morning bright light therapy could offer a low-risk way to support both mood and underlying brain processes during the earliest stages of depression. In this clip, I describe the connection between sleep, the glymphatic system, and dementia risk.